HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lipid-altering changes and pleiotropic effects of atorvastatin in patients with hypercholesterolemia.

Abstract
In this prospective study, we found beneficial short-term effects from atorvastatin therapy, including effects on low-density lipoprotein subfractions and remnant-like lipoprotein particle cholesterol, antioxidant effects, and alterations in endothelial function that may be important in early benefit from statin therapy; some effects would support much earlier benefit than previously reported. We also found long-term effects of atorvastatin, including decreased plasminogen activator inhibitor type-1 and additional significant alterations in low-density lipoprotein subfractions and endothelial function, supporting benefits from continuous long-term atorvastatin therapy beyond early reversal of hypercholesterolemia.
AuthorsKoichi Sakabe, Nobuo Fukuda, Katsunori Wakayama, Teru Nada, Hisanori Shinohara, Yoshiyuki Tamura
JournalThe American journal of cardiology (Am J Cardiol) Vol. 94 Issue 4 Pg. 497-500 (Aug 15 2004) ISSN: 0002-9149 [Print] United States
PMID15325939 (Publication Type: Journal Article)
Chemical References
  • Anticholesteremic Agents
  • Cholesterol, HDL
  • Cholesterol, LDL
  • Heptanoic Acids
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Plasminogen Activator Inhibitor 1
  • Pyrroles
  • Thiobarbituric Acid Reactive Substances
  • Triglycerides
  • Cholesterol
  • Atorvastatin
Topics
  • Adult
  • Aged
  • Anticholesteremic Agents (adverse effects, therapeutic use)
  • Atorvastatin
  • Basilar Artery (drug effects)
  • Cholesterol (blood)
  • Cholesterol, HDL (blood)
  • Cholesterol, LDL (blood)
  • Endothelium, Vascular (drug effects)
  • Female
  • Fibrinolysis (drug effects)
  • Follow-Up Studies
  • Heptanoic Acids (adverse effects, therapeutic use)
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors (adverse effects, therapeutic use)
  • Hypercholesterolemia (blood, drug therapy)
  • Long-Term Care
  • Male
  • Middle Aged
  • Plasminogen Activator Inhibitor 1 (blood)
  • Prospective Studies
  • Pyrroles (adverse effects, therapeutic use)
  • Thiobarbituric Acid Reactive Substances (metabolism)
  • Treatment Outcome
  • Triglycerides (blood)
  • Vasodilation (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: